Cite
HARVARD Citation
Villafane, G. et al. (2018). High‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study. European journal of neurology. pp. 120-127. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Villafane, G. et al. (2018). High‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study. European journal of neurology. pp. 120-127. [Online].